findmyKOL
Clinical trialNCT03667690CompletedPhase 3Interventional

Study of Rezafungin Compared to Caspofungin in Subjects With Candidemia and/or Invasive Candidiasis

SponsorCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Enrollment199CandidemiaFungal InfectionInvasive CandidiasesMycoses
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Taylor Sandison, MD, MPH

    Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

132 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina
  • Alexander Fleming Specialized Medical Institute

    Buenos Aires, Argentina

  • Allende Sanatorium

    Córdoba, Argentina

  • Cordoba Private Hospital

    Córdoba, Argentina

  • Mayo Private Sanatorium

    Córdoba, Argentina

  • Italian Hospital of Mendoza

    Mendoza, Argentina

Australia
  • Westmead Public Hospital

    Northmead, New South Wales, Australia

  • Monash Health

    Clayton, Victoria, Australia

  • Alfred Health

    Melbourne, Victoria, Australia

  • Peter Maccallum Cancer Centre

    Melbourne, Victoria, Australia

  • Royal Melbourne Hospital (rmh)

    Parkville, Victoria, Australia

Belgium
  • Brugmann University Hospital Center

    Brussels, Belgium

  • Erasme Hospital

    Brussels, Belgium

  • Saint Luc University Hospital

    Brussels, Belgium

  • University Hospital Brussels

    Brussels, Belgium

  • University Hospitals Leuven, Campus Gasthuisberg

    Leuven, Belgium

Bulgaria
  • Multiprofile Hospital for Active Treatment Puls

    Blagoevgrad, Bulgaria

  • University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov Ead

    Sofia, Bulgaria

  • University Multiprofile Hospital for Active Treatment and Emergency Medicine N.I. Pirogov Ead, Sofia, Clinic of Purulent-Septic Surgery

    Sofia, Bulgaria

China
  • the First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China

  • the Second Hospital of Anhui Medical University

    Hefei, Anhui, China

  • the Second People'S Hospital of Hefei

    Hefei, Anhui, China

  • Chongqing People'S Hospital

    Chongqing, Chongqing Municipality, China

  • Guangdong Provincial People'S Hospital

    Guangzhou, Guangdong, China

  • Guangzhou First People'S Hospital

    Guangzhou, Guangdong, China

  • the First Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China

  • Qingyuan People'S Hospital

    Qingyuan, Guangdong, China

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China

  • the Second Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • Nanjing First Hospital

    Nanjing, Jiangsu, China

  • Zibo Central Hospital

    Zibo, Shandong, China

  • West China Hospital, Sichuan University

    Chengdu, Sichuan, China

  • Huashan Hospital Affiliated Fudan University

    Shanghai, China

  • Shanghai Pulmonary Hospital

    Shanghai, China

  • General Hospital of Tianjin Medical University

    Tianjin, China

  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences

    Tianjin, China

Colombia
  • Cequin Foundation Cardiomet

    Armenia, Colombia

  • de la Costa Clinic Ltd.

    Barranquilla, Colombia

  • University Ips - Leon Xiii Clinic

    Medellín, Colombia

France
  • Amiens Picardie University Hospital - South

    Amiens, France

  • Centre Hospitalier Victor Dupouy - Argenteuil

    Argenteuil, France

92 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Oct 2018
Primary completion
7 Oct 2021
Completion
7 Oct 2021
Last update posted
6 Jan 2023
Registered enrollment
199
Registry id
NCT03667690

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.